As IL-1β is closely associated with obesity and inflammatory fatty liver disease [21,34,35], HFD-induced NAFLD may be a factor in enhancing the risk of biogenic amines. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.